Position in BBIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$19,829,722
-$4,135 QoQ
Shares Held
267,031
+3.0% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
4.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Eagle Health Investments LP holds $296,133,986 across 15 Biotechnology names. BBIO ranks #6 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
76,336 | $55,744,364 | |
| 2 | INSM |
INSMED Inc
|
224,271 | $36,672,793 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
505,809 | $28,573,150 | |
| 4 | SRRK |
Scholar Rock Holding Corp
|
494,019 | $24,285,974 | |
| 5 | TERN |
Terns Pharmaceuticals, Inc.
|
412,497 | $21,746,841 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
This page
|
267,031 | $19,829,722 | |
| 7 | ASND |
Ascendis Pharma A/S
|
86,650 | $19,819,454 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
179,322 | $18,900,538 |
All Filings in BBIO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,829,722 | 267,031 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,833,857 | 259,300 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $13,468,042 | 259,300 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $11,196,574 | 259,300 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||